Background/Aims: The aim of this study is to investigate the clinicopathological and prognostic values of miR-149 expression and its roles in colorectal cancer (CRC) progression. Methods: qRT-PCR was performed to detect miR-149 expression in CRC cell lines or tissues. explored whether miR-149 inhibits migration and invasion of CRC cells by targeting the mammalian Forkhead Box M1 (FOXM1). Results: lymph node or distant metastasis and advanced TNM stage of CRC patients. Patients with low miR-149 expression showed poorer prognosis than those with high miR-149 expression, and multivariate analyses indicated that status of miR-149 expression might be an independent inhibited growth, migration and invasion of CRC cells by targeting FOXM1. Furthermore, expression. Conclusions: miR-149 was an independent prognostic factor and could inhibit migration and invasion of CRC cells, at least partially by targeting FOXM1.
MicroRNA-149 Suppresses Colorectal

Introduction
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths worldwide, and its overall incidence is ~5% and the 5 years survival rate ranges from 40 to 60% [1] . Many progresses made in the treatment of CRC in the past decades, but the overall survival of patients with CRC is still low. Poor prognosis and survival rate are mainly due to metastasis, thus more than one-third of patients with CRC will ultimately develop metastatic diseases [2] . Due to the fact that the molecular mechanisms of CRC cell migration and invasion are processes is crucial for developing targeted therapy for CRC.
MicroRNAs (miRNAs), a class of 17-25 nucleotides small non-coding RNAs, associate suppress translation and occasionally also induce their degradation [3] . Dsyregulated miRNAs play critical roles in many human physiological and pathological processes, such as cellular growth, differentiation, apoptosis, development, malignant transformation and metastasis [4] [5] [6] . Recently, miR-149 is reported to be downregulated in many human cancers and functions as a tumor suppressor in non-small cell lung cancer, glioma and gastric cancer [7] [8] [9] . The correlations of miR-149 with CRC are also reported. Wang, et al showed that SP1
in CRC [10] . Vinci and his colleagues investigated the distribution of sequence variants of miR-146a, miR-196a, miR-499 and miR-149 in colorectal cancer (CRC) and their effects on miRNA expression [11] . Also, Du and his colleagues showed that the miR-149 rs2292832 and miR-196a2 rs11614913 polymorphisms may contribute to susceptibility to CRC [12] . These results indicated that dysregulation of miR-149 might play an important role in CRC progression and development. Although it has been reported that miR-149 inhibits nonsmall cell lung cancer cells EMT by targeting FOXM1 [13] , whether miR-149 targets FOXM1 to suppress CRC migration and invasion is not unclear and will be investigated in this report.
and tissue samples, and analyzed its clinicopathological and prognostic values. By gainand invasion of CRC cells through post-transcriptionally downregulating FOXM1, which is a master regulator of tumor metastasis. Thus, target miR-149/FOXM1 signaling will be a potential strategy for the treatment of metastatic CRC.
Materials and Methods
Cell culture
Human colorectal cancer cell lines (HCT116, LoVo and SW480) and a normal colonic cell line (NCM460) were cultured at at 37 in RPMI-1640 medium supplemented with 10% calf serum, 100 U/mL penicillin, Cancer (UICC). Patients were informed of the investigational nature of the study and each provided written informed consent prior to recruitment. None of the patients had received chemotherapy or radiation therapy. For RT-PCR and Western blot examination, all tissues were immediately frozen in liquid nitrogen and stored at -70 until use.
Taqman quantitative reverse transcription (qRT)-PCR of miRNA
Total RNA isolation from tissues was performed using mirVana miRNA Isolation Kit (Ambion, Austin, TX, USA). RNA concentrations were measured using the SPECTRAmax microplate spectrophotometer (Molecular Devices Corp). The cDNA was synthesized from 5 ng of total RNA by using the Taqman miRNA based on the threshold cycle (Ct), and relative expression levels were calculated as 2 -[(Ct of 149)-(Ct of U6)] after normalization with reference to expression of U6 small nuclear RNA.
Quantitative real-time PCR of mRNAs
To measure the relative expression of mRNAs, two micrograms of total RNAs of each sample were Quantitative real-time PCR was carried out using realtime PCR with the SYBR Green reporter following manufacturer's protocol. Sequences of PCR primers (MMP-2, MMP-9, VEGF-A and uPA) were described Cycler II thermocycler. Data were analyzed using Ct value and were normalized by the expression of control mRNA GAPDH in each sample.
Western blotting assay
7.4), 1% NP-40, 0.25% sodium deoxycholate, 150mM NaCl, 1mM ethylenediaminetetraacetic acid, protease samples were stored at -134 until use. Proteins were separated by sodium dodecyl sulfate-polyacrylamide chemiluminescence (ECL) after antibody binding. The following antibodies are used: anti-FOXM1, MMP-2, MMP-9, VEGF-A, uPAR and GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The membranes were then incubated with a horseradish peroxidase-conjugated secondary antibody (Sigma, USA). The proteins were detected by an enhanced chemiluminescence detection system, and light emission was captured on
Transfection of miRNA mimics, inhibitors or plasmid vectors
MiR-149 mimics or inhibitor (anti-miR-149) and their negative control oligonucleotides (miR-NC mimics or anti-miR-NC) were obtained from Ambion Inc (Austin, TX, USA). The small hairpin RNA (shRNA) plasmid vector targeting FOXM1 (pSil/shFOXM1) and control vector (pSil/shcontrol) were successfully constructed previously [15] . The open reading frame of FOXM1 that was generated by PCR was then inserted into the pEGFP-C1 expression vector which was named pEGFP/FOXM1. The recombinant vector were performed using Lipofectamine™ 2000 (Invitrogen, USA) according to the instructions provided by the manufacturer. The cells were transfected with those recombinant DNA vectors containing a G418 selection maintained in G418 at 100 mg/ml.
3-(4,5-dimethylthazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay
-). Then, the cells were incubated at 37 for 4 h, the reaction was stopped by the addition of 200 ml/well of DMSO, lysing for 10 min. The protracted cell growth curve and the results of the inhibitory rates of cell growth were applied to absorbance (A) at 540 nm using Versamax microplate reader (Molecular Devices, Sunnyvale, CA). 
Statistical assay
For continuous variables, data are expressed as mean ± standard deviation (SD). The Chi-squared test in CRC. The overall survival (OS) curves were plotted using the Kaplan-Meier method and were evaluated survival was analyzed using the univariate and multivariate Cox proportional hazards model. Differences P<0.05. Statistical analysis was performed using SPSS 17.0 software program (SPSS Inc., Chicago, Illinois, USA). (Table. 2). These data suggested that downregulation of miR-149 might play an important role in CRC progression and metastasis.
MiR-149 inhibits migration and invasion of CRC cells
To further determine the effects of miR-149 on malignant phenotypes of CRC cells, LoVo endogenous miR-149, whereas HCT116 cells with low miR-149 expression were transfected (Fig. 3A) . First, we performed MTT assay to analyze the effect of miR-149 on growth of CRC cells, and showed that upregulation of miR-149 could moderately increase the growth of tissues with metastasis, we next determine the effects of miR-149 expression in migration and invasion of CRC cells. The wound healing assay indicated that upregulation of miR-149 could induce a slower closing of scratch wounds in HCT116 cells and downregulation of miR-149 could induce a faster closing of scratch wounds in LoVo cells (Fig. 3C) . Similarly, Fig. 5D ). These data suggest that FOXM1 is a direct target of miR-149 in CRC cells.
To further investigate the effects of FOXM1 expression on migration and invasion of CRC cells, pSil/shFOXM1 was stably tansfected into CRC cells (HCT116 and LoVo) and P<0.05; Fig. 6A ). Next, results from MTT assay indicated that silencing of FOXM1 could lead to the decreased capacity of growth in HCT116 and LoVo cells (Fig. 6B) . Also, wound healing and Martrigel Fig. 6C and D) . These results clearly indicate that silencing of FOXM1 mimics the effects of miR-149 overexpression on malignant phenotypes of CRC cells.
Overexpression of FOXM1 partially reverses the effects of miR-149 upregulation on malignant phenotypes of CRC cells
To further determine the roles of FOXM1 in phenotypical changes of CRC cells induced by miR-149, HCT116 cells were co-transfected with miR-149 mimics (or miR-NC mimics) and pEGFP/FOXM1 vector. 48h after co-tranfection, qRT-PCR and Western blotting assays were performed to detect the expression of FOXM1 mRNA and protein, and results showed that the co-transfection could rescue the decreased expression of FOXM1 mRNA and protein in HCT116 cells induced by miR-149 mimics (Fig. 7A) . It was observed that overexpression 
Upregulation of miR-149 inhibits expression of MMPs, VEGF-A and uPAR in CRC cells by downregulating FOXM1
Then, we explored the underlying molecular mechanisms involved in miR-149/FOXM1-promoting migration and invasion of CRC cells. Previously, FOXM1 has been reported to promote the expression of many factors that are involved in the degradation of extra cellular matrix and angiogenesis such as uPAR, MMP-2, MMP-9, and vascular endothelial growth factor A (VEGF-A) [16, 17] . Thus, qRT-PCR and Western blotting assays were performed to detect the effects of miR-149 or FOXM1 expression on the mRNA and protein expression of MMP-2, MMP-9, VEGF-A and uPAR in CRC cells. It was observed that the mRNA expression levels of MMP-2, MMP-9, VEGF-A and uPAR in miR-149 mimics or pSil/shFOXM1-transfected in miR-149 mimics or pSil/shFOXM1-transfected HCT116 cells were also reduced in comparison with miR-NC mimics or pSil/shcontrol-transfected cells (Fig. 8B) . Furthermore, tissues with high miR-149 expression (n=33) (Fig. 9A-D) . These data showed that miR-149 regulates the expression of MMPs, VEGF-A and uPAR in CRC through downregulating FOXM1 expression.
FOXM1, upregulated in metastatic CRC tissues, is inversely associated with miR-149 expression
To investigate the importance of FOXM1 in primary CRC, we compared the level of FOXM1 expression 78 CRC tissue samples and 20 normal colon tissues, which is normalized tissues compared to the normal colon tissues (P<0.01; Fig. 10A ). Also, in comparison with in CRC tissues (P<0.01; Fig. 10B ). Meanwhile, we detected the expression of FOXM1 in CRC tissues with or without metastasis, and showed that the expression of the FOXM1 mRNA in that in CRC tissues without metastasis (nmCRC, n=31) (P<0.01; Fig. 10C ). Then, we evaluated the correlation between FOXM1 mRNA and miR-149 expression in 78 primary CRC tissues, and showed that expression of FOXM1 P<0.001; Fig. 10D ). This
Discussion
Metastasis has become the major cause of death in CRC patients, and this metastatic underlying each step still remain obscure. Recently, miRNAs are recognised as master [31] , but miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells [32] . The roles of miR-149 in CRC metastasis are still unclear and need to be further elucidated. In this study, we showed that More importantly, the expression level of miR-149 in CRC tissues with lymph node or distant metastasis is lower than that in CRC tissues without metastasis. Then, we further analyzed miR-149 expression was closely correlated with higher incidence of lymph node or distant metastasis, advanced TNM stage and poorer prognosis of CRC patients. Then, we further performed gain-of-function assays in HCT116 cell line (low-miR-149) and loss-of -function assays in LoVo cell line (high-miR-149). Upregulation of miR-149 inhibits growth, migration and invasion of HCT116 cells, while downregulation of miR-149 promotes growth, migration mRNAs of miR-149 will contribute to characterizing the potential molecular mechanisms of miR-149-mediated phenotypical changes in CRC cells. By three target scan databases, the 3'-UTR of FOXM1 mRNA possesses a miR-149-targeted seed sequence, suggesting that FOXM1 may be a putative target of miR-149.
[33]. This protein is a important regulator of both G1-S and G2-M phases of the cell cycle and mitotic spindle integrity, and its overexpression could lead to malignant transformation and factors is found in a variety of human cancers, and has been reported to play important roles in tumor angiogenesis, invasion, and metastasis [35] . In previous study, we have reported potential of CRC and a poorer prognosis. However, the molecular mechanisms involved in Recently, Huang and his colleagues showed that FOXM1c contributes to pancreatic cancer development and progression by enhancing uPAR gene transcription, and thus, tumor EMT and metastasis [38] . By qRT-PCR and Western blotting assays, we also found that overexpression of miR-149 or silencing of FOXM1 could induce the decreased expression of overexpression of FOXM1 could reverse the effects of miR-149 upregulation on those genes in metastatatic CRC tissues compared to the non-metastatic CRC tissues, and the expression of FOXM1 was inversely correlated with miR-149 expression in CRC tissues. In summary, downregulation of miR-149 plays critical roles in CRC metastasis, and status of miR-149 expression may be an independent prognostic factor for patients. Also, miR-149 inhibits migration and invasion of CRC cells via downregulation of MMPs, VEGF-A and uPAR, at least partially by targeting FOXM1. implying the re-expression of miR-149 will be a potential therapeutic strategy for the treatment of metastatic CRC. Since the size of tissue sample in this study is small, further investigation of a larger patient population metastasis. Moreover, as one miRNA could regulate multiple target genes and one gene could also be regulated by multiple miRNAs, whether miR-149 might regulate other target genes which are involved in CRC metastasis needs to be further elucidated.
